Grade 1 Endometrioid Endometrial Carcinoma Presenting with Pelvic Bone Metastasis: A Case Report and Review of the Literature

por Nguyen, My-Linh T., LaFargue, Christopher J., Pua, Tarah L., Tedjarati, Sean S.
Publicado 2013

Routine Cystoscopy After Robotic Gynecologic Oncology Surgery

por Nguyen, My-Linh T., Stevens, Erin, LaFargue, Christopher J., Karsy, Michael, Pua, Tarah L., Gorelick, Constantine, Tedjarati, Sean S., Pradhan, Tana S.
Publicado 2014

Testing mutual exclusivity of ETS rearranged prostate cancer

por Svensson, Maria A, LaFargue, Christopher J, MacDonald, Theresa Y, Pflueger, Dorothee, Kitabayashi, Naoki, Santa-Cruz, Ashley M, Garsha, Karl E, Sathyanarayana, Ubaradka G, Riley, Janice P, Yun, Chol S, Nagy, Dea, Kosmeder, Jerry W, Pestano, Gary A, Tewari, Ashutosh K, Demichelis, Francesca, Rubin, Mark A
Publicado 2011

CD63-mediated cloaking of VEGF in small extracellular vesicles contributes to anti-VEGF therapy resistance

por Ma, Shaolin, Mangala, Lingegowda S., Hu, Wen, Bayaktar, Emine, Yokoi, Akira, Hu, Wei, Pradeep, Sunila, Lee, Sanghoon, Piehowski, Paul D., Villar-Prados, Alejandro, Wu, Sherry Y., McGuire, Michael H., Lara, Olivia D., Rodriguez-Aguayo, Cristian, LaFargue, Christopher J., Jennings, Nicholas B., Rodland, Karin D., Liu, Tao, Kundra, Vikas, Ram, Prahlad T., Ramakrishnan, Sundaram, Lopez-Berestein, Gabriel, Coleman, Robert L., Sood, Anil K.
Publicado 2021

Overcoming adaptive resistance to anti-VEGF therapy by targeting CD5L

por LaFargue, Christopher J., Amero, Paola, Noh, Kyunghee, Mangala, Lingegowda S., Wen, Yunfei, Bayraktar, Emine, Umamaheswaran, Sujanitha, Stur, Elaine, Dasari, Santosh K., Ivan, Cristina, Pradeep, Sunila, Yoo, Wonbeak, Lu, Chunhua, Jennings, Nicholas B., Vathipadiekal, Vinod, Hu, Wei, Chelariu-Raicu, Anca, Ku, Zhiqiang, Deng, Hui, Xiong, Wei, Choi, Hyun-Jin, Hu, Min, Kiyama, Takae, Mao, Chai-An, Ali-Fehmi, Rouba, Birrer, Michael J., Liu, Jinsong, Zhang, Ningyan, Lopez-Berestein, Gabriel, de Franciscis, Vittorio, An, Zhiqiang, Sood, Anil K.
Publicado 2023

SOX2 Is an Amplified Lineage Survival Oncogene in Lung and Esophageal Squamous Cell Carcinomas

por Bass, Adam J., Watanabe, Hideo, Mermel, Craig H., Yu, Soyoung, Perner, Sven, Verhaak, Roel G., Kim, So Young, Wardwell, Leslie, Tamayo, Pablo, Gat-Viks, Irit, Ramos, Alex H., Woo, Michele S., Weir, Barbara A., Getz, Gad, Beroukhim, Rameen, O’Kelly, Michael, Dutt, Amit, Rozenblatt-Rosen, Orit, Dziunycz, Piotr, Komisarof, Justin, Chirieac, Lucian R., LaFargue, Christopher J., Scheble, Veit, Wilbertz, Theresia, Ma, Changqing, Rao, Shilpa, Nakagawa, Hiroshi, Stairs, Douglas B., Lin, Lin, Giordano, Thomas J., Wagner, Patrick, Minna, John D., Gazdar, Adi F., Zhu, Chang Qi, Brose, Marcia S., Cecconello, Ivan, Ribeiro, Ulysses, Marie, Suely K., Dahl, Olav, Shivdasani, Ramesh A., Tsao, Ming-Sound, Rubin, Mark A., Wong, Kwok K., Regev, Aviv, Hahn, William C., Beer, David G., Rustgi, Anil K., Meyerson, Matthew
Publicado 2009